Ameliorating Iron Overload in Intestinal Tissue of Adult Male Rats: Quercetin vs Deferoxamine

Ameliorating Iron Overload in Intestinal Tissue of Adult Male Rats: Quercetin vs Deferoxamine

Objective. The aim of our study is to compare the role of the new natural alternative (Quercetin) with the current iron-chelation therapy (Deferoxamine (DFO)) in the effect of iron overload on small intestinal tissues and to investigate the possible underlying molecular mechanisms of such toxicity....

Full description

Bibliographic Details
Main Authors:	Arwa A. El-Sheikh, Shimaa Hamed Ameen, Samaa Salah AbdEl-Fatah
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Journal of Toxicology
Online Access:	http://dx.doi.org/10.1155/2018/8023840

Similar Items

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
by: Wu D, et al.
Published: (2018-05-01)

PEGylation of Deferoxamine for Improving the Stability, Cytotoxicity, and Iron-Overload in an Experimental Stroke Model in Rats
by: Jiake Xu, et al.
Published: (2020-09-01)

Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
by: Gotsis Efstathios D, et al.
Published: (2011-07-01)

Effect of deferoxamine therapy on insulin resistance in end-stage renal disease patients with iron overload
by: Alsayed Ahmed Alnahal, et al.
Published: (2014-01-01)

Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob/ob mice
by: Hong-Fa Yan, et al.
Published: (2018-04-01)

Co-administration of silymarin and deferoxamine against kidney, liver and heart iron deposition in male iron overload rat model
by: Mitra Navidi-Shishaone, et al.
Published: (2014-01-01)

A Novel Star Like Eight-Arm Polyethylene Glycol-Deferoxamine Conjugate for Iron Overload Therapy
by: Bohong Yu, et al.
Published: (2020-04-01)

Comparison of Deferoxamine, Activated Charcoal, and Vitamin C in Changing the Serum Level of Fe in Iron Overloaded Rats
by: Reza Ghafari, et al.
Published: (2014-02-01)

Effect of Combined versus Monotherapy with Deferoxamine and Deferiprone in Iron Overloaded Thalassemia Patients: a Randomized Clinical Trial
by: Sasan Hejazi, et al.
Published: (2016-06-01)

Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion-dependent β-thalassemia
by: Hayder M Al-Kuraishy, et al.
Published: (2017-01-01)

Re: "Protective Role of Silymarin and Deferoxamine against Iron Dextran-Induced Renal Iron Deposition in Male Rats," and "Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model"
by: Safoora Mazaheri, et al.
Published: (2014-01-01)

Iron accumulates in Huntington's disease neurons: protection by deferoxamine.
by: Jianfang Chen, et al.
Published: (2013-01-01)

Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
by: Shahla Ansari, et al.
Published: (2017-06-01)

Correction: Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
by: Jianfang Chen, et al.
Published: (2013-01-01)

Correction: Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine.
by: Jianfang Chen, et al.
Published: (2013-01-01)

The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity
by: Masanari Umemura, et al.
Published: (2017-08-01)

Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine
by: Mohamed Abdel Malik Hassan, et al.
Published: (2016-05-01)

Protective role of silymarin and deferoxamine against iron dextran-induced renal iron deposition in male rats
by: Mehdi Nematbakhsh, et al.
Published: (2013-01-01)

Quercetin inhibits intestinal iron absorption and ferroportin transporter expression in vivo and in vitro.
by: Marija Lesjak, et al.
Published: (2014-01-01)

Formulation and In-Vitro Characterization of Chitosan-Nanoparticles Loaded with the Iron Chelator Deferoxamine Mesylate (DFO)
by: Maria Lazaridou, et al.
Published: (2020-03-01)

Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction.
by: Yasumasa Ikeda, et al.
Published: (2014-01-01)

Urinary iron excretion induced by intravenous infusion of deferoxamine in ß-thalassemia homozygous patients
by: Boturão-Neto E., et al.
Published: (2002-01-01)

Despite Blocking Doxorubicin-Induced Vascular Damage, Quercetin Ameliorates Its Antibreast Cancer Activity
by: Hanan A. Henidi, et al.
Published: (2020-01-01)

Re: Protective Role of Silymarin and Deferoxamine against Iron Dextran - Induced Renal Iron Deposition in Male Rats
by: Azar Baradaran, et al.
Published: (2014-01-01)

Comment on: The protective role of silymarin and deferoxamine against iron dextran-induced renal iron deposition in male rats
by: Azar Baradaran
Published: (2013-01-01)

Comparative Efficacy of Deferiprone, Deferoxamine and Combination of Deferiprone and Deferoxamine on Serum Ferritin Value in Beta-Thalassemia Patients
by: Nargesbeygom Mirbehbahani, et al.
Published: (2015-01-01)

Decreasing cardiac iron overload with Amlodipine and Spirulina in children with β-thalassemia
by: Sahar M. El-Haggar, et al.
Published: (2018-09-01)

Comparison of cardiac dysfunction in thalassemia major patients using deferoxamine or deferiprone as an iron-chelating agent
by: Rosalina Josep, et al.
Published: (2012-10-01)

Effect of Iron Chelator Deferoxamine on the Ribosome Biogenesis in Human Breast Cancer MCF-7 Cells
by: CHENG, YA-YUN, et al.
Published: (2016)

Quercetin Ameliorates Experimental Autoimmune Myocarditis in Rats
by: Marina Milenković, et al.
Published: (2010-09-01)

Therapeutic Value of Silymarin as Iron Chelator in Children with Beta Thalassemia with Iron Overload
by: adel abd elhaleim hagag
Published: (2014-08-01)

The effects of quercetin on iron metabolism
by: Hoque, Rukshana
Published: (2014)

Screening for Iron Overload: Lessons from the HEmochromatosis and IRon Overload Screening (HEIRS) Study
by: Paul C Adams, et al.
Published: (2009-01-01)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
by: Taher AT, et al.
Published: (2016-12-01)

Study of the mechanism of iron chelatingagent-deferoxamine induced cell death in hepatoma HepG2 cells
by: Guei-Lan Chen, et al.
Published: (2000)

Effect of microRNA-210 induced by deferoxamine on iron metabolism in rat L6 skeletal cell
by: Han-Chich Feng, et al.
Published: (2014)

Iron chelating agents for iron overload diseases
by: Guido Crisponi, et al.
Published: (2014-09-01)

Inherited Disorders of Iron Overload
by: Kostas Pantopoulos, et al.
Published: (2018-10-01)

Renal clearable nanochelators for iron overload therapy
by: Homan Kang, et al.
Published: (2019-11-01)

Quercetin Dietary Supplementation Advances Growth Performance, Gut Microbiota, and Intestinal mRNA Expression Genes in Broiler Chickens
by: Mervat A. Abdel-Latif, et al.
Published: (2021-08-01)